Crossref

1. A Comprehensive Long-Term Prognosis of Chronic Hepatitis C Patients With Antiviral Therapy; A Meta-Analysis of Studies From 2008 to 2014

- Ya Wen

- Yi Xiang Zheng

- De Ming Tan

2. Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourableIL28Bpolymorphism

- Victoria Ekstrom

- Rajneesh Kumar

- Yi Zhao

- Mei Ling Yee

- Cynthia Sung

- Dorothy Toh

- Poh Yen Loh

- Jessica Tan

- Eng Kiong Teo

- Wan Cheng Chow

3. Polymorphism in interferon λ3/interleukin‐28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy

- Anwar Jamal Khan

- Vivek Aanand Saraswat

- Prabhat Ranjan

- Devendra Parmar

- Tajwar Singh Negi

- Samir Mohindra

4. Role of Interferon Gamma and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 1 Single Nucleotide Polymorphism in Natural Clearance and Treatment Response of HCV Infection

- Sikandar Azam

- Sobia Manzoor

- Muhammad Imran

- Javed Ashraf

- Sarah Ashraf

- Saleha Resham

- Eijaz Ghani

5. Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis

- Qin Wu

- Cong Wang

- En Qiang Chen

- Hong Tang

- Zhen Zhen Li

- Xue Zhong Lei

6. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study

- Li-Bo Yan

- Hui-Ying Rao

- Yuan-Ji Ma

- Lang Bai

- En-Qiang Chen

- Ling-Yao Du

- Rui-Feng Yang

- Lai Wei

- Hong Tang